For Private Equity and Search Funds · Buy Side
From first look to exit, one deal record.
Screen against your mandate, review the data room, model the returns, draft the IC Memo, then track the business against the plan you underwrote.
Your deal team reads fewer pages and decides faster, with every claim traced to the data room. The rigour of a fund's deal team, for a searcher with a data room and a deadline.
- Sector: business services In mandate
- EBITDA €4.2M Within €2M to €10M
- Geography: DACH In mandate
- Top customer 31% Above your 25% limit
- Leverage 3.1x vs 4.0x covenant
- Pricing lever Behind plan
One record
What you learn at diligence is still there when you sell. One deal record moves through every stage, and nothing is rebuilt along the way.
- 01ScreeningMandate fit
- 02DiligenceFindings, questions, QoE
- 03OwnedActuals vs IC budget
- 04ExitSale materials from the same room
Stage by stage
Decide faster, on evidence you can trace. Your committee argues about the deal, not about the numbers.
- 01
Screening
Triage what the banker sent against your Investment Mandate: pursue, pass, or ask for more. Criterion by criterion.
- Every inbound deal checked against your mandate and track record
- A fit check on every criterion, and a snapshot of the numbers
- Pass in minutes, with the verdict kept on the deal
ScreeningProject Kestrel- Sector: business services In mandate
- EBITDA €4.2M Within €2M to €10M
- Geography: DACH In mandate
- Top customer 31% Above your 25% limit
Recommendation: Pursue - 02
Diligence
Every finding ranked by what it means for the deal. Questions go to the seller on a secure link, and the answers come back into the deal.
- Findings grouped by outcome, with the money at stake counted once
- Contracts read clause by clause, quoted with the page
- Quality of Earnings: add-backs, cash conversion, working capital, net debt
- Meeting notes read against your open questions
Diligence SummaryProject KestrelWalk away0Price2€1.4MContract3Post-closing4- Customer can terminate on change of control Contract
- Working capital below the 3-year average Price
- 03
Returns
An LBO built from the verified numbers, with returns by exit year, tested against your mandate's targets.
- Sources and uses, debt schedule, returns by exit year
- IRR and multiple against the targets in your mandate
- The same model becomes the plan you track after closing
LBO ReturnsBase Case- Entry multiple 7.5x EBITDA
- Exit year Year 5
- IRR 24.8% vs 20% target
- Money multiple 2.9x
- 04
IC Memo
The Investment Committee Memorandum, drafted from the thesis, the findings and the model. The recommendation stays yours to make.
- Built from what is already in the deal: thesis, diligence, returns, mandate
- Open items shown as open, never papered over
- The recommendation is set by a person, not by the software
IC MemoProject Kestrel- Mandate fit5 of 6 criteria
- Open itemsAwaiting QoE sign-off
- RecommendationPending your decision
- 05
Ownership
Each period against the budget approved at IC, with covenants, KPIs and the Value Creation Plan. The Board Pack is drafted for you.
- Actuals against the IC budget, which is never rewritten by a re-forecast
- Leverage against the covenant, cash and debt at every period end
- The Value Creation Plan, lever by lever, with an owner and a date
- A Board Pack draft each quarter, with a paragraph for your investors
Portfolio · KestrelEBITDA vs IC budgetQ1Q2Q3Q4Actual IC budget- Leverage 3.1x vs 4.0x covenant
- Pricing lever Behind plan
- 06
Exit
The data room you built at diligence is still there. The sale materials come from it.
- One deal record from screening to sale, nothing rebuilt
- Your thesis's exit view, checked against how the business actually performed
- Teaser and IM generated from the data room when you are ready to sell
ExitProject Kestrel- Periods recorded since closing 11 quarters
- Thesis exit view Trade buyer at 9x
- EBITDA vs underwriting +14%
- Sale materials Ready to generate
- Sector: business services In mandate
- EBITDA €4.2M Within €2M to €10M
- Geography: DACH In mandate
- Top customer 31% Above your 25% limit
- Customer can terminate on change of control Contract
- Working capital below the 3-year average Price
- Entry multiple 7.5x EBITDA
- Exit year Year 5
- IRR 24.8% vs 20% target
- Money multiple 2.9x
- Mandate fit5 of 6 criteria
- Open itemsAwaiting QoE sign-off
- RecommendationPending your decision
- Leverage 3.1x vs 4.0x covenant
- Pricing lever Behind plan
- Periods recorded since closing 11 quarters
- Thesis exit view Trade buyer at 9x
- EBITDA vs underwriting +14%
- Sale materials Ready to generate
Built for how you invest
A fund or a searcher, the same rigour.
Pipeline
Every intermediary and every deal, from sourced to IC, with each screening verdict kept on the deal. Hundreds of targets, one pipeline, no spreadsheet. Screen fast and spend your time on the few that matter.
Committee
An IC Memo drafted from the evidence, with the open items shown and the decision left to your committee. The investment memo your investors expect, built from the diligence you actually did.
After Closing
Every portfolio company on one screen, against the budget approved at IC, with what needs your attention first. Run the company with the plan you underwrote, and send your investors a quarterly update they will actually read.
Your mandate, built in
Every deal measured against what you buy.
Write down your Investment Mandate and your track record once. Every screen, every thesis and every IC Memo is measured against them, so a deal that does not fit says so on page one.
- Sectors, size, geography and the limits you hold to
- Target returns and hold period
- Your track record, for the memo and for your investors
- Your firm's own diligence playbook
- Sectors Business services, healthcare
- EBITDA €2M to €10M
- Geography DACH, Benelux
- Customer concentration Top customer under 25%
- Target returns 20% IRR, 2.5x
- Hold period 4 to 6 years
What comes out
What goes to your committee. The memo, the model and the Board Pack, drafted from the evidence and cited to the source.
We only buy a few companies a year. Is it worth it?
The work is in the deals you do not buy. Screening and diligence are where the hours go, and that is what NaS_OS takes off your team.
Does the software make the investment decision?
No. It drafts the IC Memo and shows the evidence. The recommendation is a control a person sets, and the memo says pending until they do.
Is this full due diligence?
No. It is a thorough review of the data room that gets your advisors a cleaner file and your team the right questions, faster. It does not replace legal or accounting diligence.
What happens after closing?
The deal becomes a portfolio company in the same record. You report each period against the IC budget, track covenants and the Value Creation Plan, and get a Board Pack draft each quarter.
We are a search fund. Is it too much?
It is built so one person can run a fund's process: screen many targets, go deep on the one that matters, and report to your investors once you own it.
Bring the next deal on your desk.
We will run NaS_OS on a data room you are looking at now, on the call, from screening to a first IC Memo.